ConductScience.org, home

Paper28693200

Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells.

Liu T and 6 others. Oncol Lett, 2017. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells. Papers, record 28693200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28693200

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells.
PubMed
Journal
Oncol Lett
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2020-10-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu TTianhua
2Liu RRiqiang
3Zhang SShu
4Guo KKun
5Zhang QQinle
6Li WWei
7Liu YYinkun

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121289447Glycan changes: cancer metastasis and anti-cancer vaccines.J Biosci2010https://conductscience.org/library/papers/21289447PubMed
23476546Purification and some properties of fucosyltransferase in human parotid saliva.J Dent Res1987https://conductscience.org/library/papers/3476546PubMed
315466206BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.Cancer Res2004https://conductscience.org/library/papers/15466206PubMed
419157620Alteration of protein glycosylation in liver diseases.J Hepatol2009https://conductscience.org/library/papers/19157620PubMed
510438459Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines.J Biol Chem1999https://conductscience.org/library/papers/10438459PubMed
624629138Comprehensive profiling of accessible surface glycans of mammalian sperm using a lectin microarray.Clin Proteomics2014https://conductscience.org/library/papers/24629138PubMed
721921256International trends in liver cancer incidence rates.Cancer Epidemiol Biomarkers Prev2011https://conductscience.org/library/papers/21921256PubMed
824724545Altered N-Glycan expression profile in epithelial-to-mesenchymal transition of NMuMG cells revealed by an integrated strategy using mass spectrometry and glycogene and lectin microarray analysis.J Proteome Res2014https://conductscience.org/library/papers/24724545PubMed
915903293Protein glycosylation: new challenges and opportunities.J Org Chem2005https://conductscience.org/library/papers/15903293PubMed
1017022640Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.J Proteome Res2006https://conductscience.org/library/papers/17022640PubMed
1111819844Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.World J Gastroenterol2001https://conductscience.org/library/papers/11819844PubMed
1223977005Cell surface glycan alterations in epithelial mesenchymal transition process of Huh7 hepatocellular carcinoma cell.PLoS One2013https://conductscience.org/library/papers/23977005PubMed
1326556863Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells.Oncotarget2015https://conductscience.org/library/papers/26556863PubMed
142953071Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis.Science1987https://conductscience.org/library/papers/2953071PubMed
1518650514Sorafenib in advanced hepatocellular carcinoma.N Engl J Med2008https://conductscience.org/library/papers/18650514PubMed
1621538283Genetics of hepatobiliary carcinogenesis.Semin Liver Dis2011https://conductscience.org/library/papers/21538283PubMed
1727203677Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma.Oncotarget2016https://conductscience.org/library/papers/27203677PubMed
1824255131Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma.Mol Cell Proteomics2014https://conductscience.org/library/papers/24255131PubMed
1925727145Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.Adv Cancer Res2015https://conductscience.org/library/papers/25727145PubMed
2014697136[Changes of alkaline phosphatase sugar chains in hepatocellular carcinoma tissue].Zhonghua Gan Zang Bing Za Zhi2003https://conductscience.org/library/papers/14697136PubMed

See all 32 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
41961075Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma.Cancer Immunol Immunother2026https://conductscience.org/library/papers/41961075PubMed
40368336Glycoproteomics of Gastrointestinal Cancers and Its Use in Clinical Diagnostics.J Proteome Res2025https://conductscience.org/library/papers/40368336PubMed
37920152Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma.Front Oncol2023https://conductscience.org/library/papers/37920152PubMed
37609076Post-translational modifications and immune responses in liver cancer.Front Immunol2023https://conductscience.org/library/papers/37609076PubMed
37193819Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications.Oncogene2023https://conductscience.org/library/papers/37193819PubMed
36072925Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36072925PubMed
35044085Glycan signatures for the identification of cisplatin-resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hCG).Cancer Med2022https://conductscience.org/library/papers/35044085PubMed
33728291Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models.Can J Gastroenterol Hepatol2021https://conductscience.org/library/papers/33728291PubMed
33203790Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma.Aging (Albany NY)2020https://conductscience.org/library/papers/33203790PubMed
31024205Hepatocellular Carcinoma: Etiology and Current and Future Drugs.J Clin Exp Hepatol2019https://conductscience.org/library/papers/31024205PubMed

Download CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28693200

GET https://conductscience.org/api/papers/v1/28693200/references?page=2